News & Perspective

Sep 11, 2002

Sep 11, 2002

IOM says military vaccine program needs revamping, more money

(CIDRAP News) – The Department of Defense's (DoD's) vaccine acquisition program is poorly organized and underfunded, making it difficult for the department to obtain important vaccines and maintain the supply of existing ones, according to a new report from the Institute of Medicine (IOM).

Sep 11, 2002

Sep 11, 2002

MMWR will post terrorism-related reports ahead of schedule

(CIDRAP News) – Morbidity and Mortality Weekly Report will publish electronic reports related to terrorism and other public health emergencies whenever necessary instead of waiting for the usual weekly publication day, the Centers for Disease Control and Prevention (CDC) announced yesterday.

Sep 10, 2002

Sep 10, 2002

Value of 'syndromic surveillance' for bioterrorism unclear from post-Sep 11 experience

(CIDRAP News) – After the Sep 11 attacks in New York City, health officials quickly launched a program of syndromic surveillance—the classification and counting of emergency department cases according to whether or not they initially looked like a disease potentially caused by bioterrorism. The goal was to provide an early warning of any biological attack.

Sep 09, 2002

Sep 09, 2002

Anthrax decontamination workers should get vaccine or antibiotics, CDC says

(CIDRAP News) – Workers who decontaminate buildings tainted with anthrax (Bacillus anthracis) spores should be vaccinated against the disease or receive preventive antibiotic treatment, according to new guidelines from the Centers for Disease Control and Prevention (CDC).

Sep 06, 2002

Sep 06, 2002

Effect of antibiotics on HUS risk in E coli patients called unclear

(CIDRAP News) – A recent meta-analysis does not support the idea that antibiotic treatment increases the risk of hemolytic uremic syndrome (HUS) in patients with Escherichia coli O157:H7 enteritis, but the authors say the question isn't settled yet.

Sep 05, 2002

Sep 05, 2002

Acambis reports successful phase I trial of cell-culture-grown smallpox vaccine

(CIDRAP News) Ð The smallpox vaccine being produced by Acambis plc for the US government as part of the nation's bioterrorism preparedness program worked well in a Phase I trial, Acambis officials announced this week.

The vaccine, called ACAM1000, generated a characteristic skin lesion or "take" in all those vaccinated, and there were no serious or unusual side effects, the company reported in a Sep 3 news release.

Sep 04, 2002

Sep 04, 2002

Smallpox vaccination decision in White House hands

(CIDRAP News) – The Department of Health and Human Services (HHS) recently sent a recommendation on smallpox vaccination policy to President Bush, but HHS officials still are not confirming reports that it calls for vaccinating as many as 500,000 healthcare workers.

"I can't confirm anything other than that the recommendation went to the White House," Bill Pierce, an HHS spokesman in Washington, DC, told CIDRAP News today.

Aug 30, 2002

Aug 30, 2002

Smallpox vaccine's effect may last 35 years, researchers say

(CIDRAP News) – The results of a small study reported this week suggest that the immunity induced by smallpox vaccination may last 35 years or longer—considerably longer than experts have generally believed.

Aug 30, 2002

Aug 30, 2002

Produce protection spawns new products

(CIDRAP News) – As foodborne diseases increase, innovations for improving food safety are sure to follow. And, in fact, such practices are already showing up in grocery stores and at food science institutions around the country.

Aug 29, 2002

Aug 29, 2002

CDC touts improvements in terrorism-response capability over past year

(CIDRAP News) Ð The Centers for DiseaseControl and Prevention (CDC) is much better prepared to deal with a terroristattack now than it was a year ago, before Sep 11 and the subsequent anthraxattacks, CDC officials said this week.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»